Methyl 1-(4-chlorophenyl)cyclopropanecarboxylate, 95.0%, 5g

3-Chloro-4-cyanobenzotrifluoride, 98.0%, 100g

N-[(1R*,4R*)-4-Aminocyclohexyl]nicotinamide dihydrochloride, 1g

Boc-Phe-Leu-OH, 97.5%, 250mg

4-(3,4-Dimethylphenyl)-thiazol-2-ylamine, 95.0%, 2.5g

6-Bromopyrazin-2(1H)-one, 98+%, 100mg

(R)-3-Amino-4-(3-chlorophenyl)butanoic acid hydrochloride, 95.0%, 250mg

((4-(Bromomethyl)phenyl)sulfonyl)(2-indol-3-ylethyl)amine, 95.0%, 1g

tert-Butyl 4-(aminomethyl)-4-hydroxypiperidine-1-carboxylate oxalate, 95.0%, 5g

Récipients autoclavables avec couvercle rectangulaire, 27 l, 1 pièce

2-(Azetidin-3-yloxy)-3,5-dichloropyridine, 98%, 250mg

tert-Butyl 2-(methylamino)-2-oxoethylcarbamate, 95%, 500mg

3-METHYL-2-PENTENOIC ACID, 97.0%, 250mg